Mintz advised Vida Ventures, a next-generation life sciences venture firm, on its $600 million fundraise of Vida Ventures II, LLC (“Vida II”), which will be used to further the firm’s life sciences platform. The oversubscribed fund closed on August 1, 2019.
Vida Ventures has a bicoastal presence and leverages its scientific and clinical skills, extensive industry network, operating and investing experience to build life science companies and provide funding for companies across research and development stages. With the close of Vida II, Vida has approximately $1 billion under management in less than two years since inception.
The Mintz team advising on the fundraise was led by Daniel DeWolf, Chair of Mintz’s Technology Practice Group, and Talia Primor.
A press release from Vida Ventures is available here.
For more information about Mintz, please visit www.mintz.com.